- Home
- TORO vs BEAT Comparison
TORO vs BEAT Comparison
Compare TORO & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- BEAT
- Stock Information
- Founded
- TORO 2022
- BEAT 2015
- Country
- TORO Cyprus
- BEAT United States
- Employees
- TORO N/A
- BEAT N/A
- Industry
- TORO Marine Transportation
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- TORO Consumer Discretionary
- BEAT Technology
- Exchange
- TORO Nasdaq
- BEAT Nasdaq
- Market Cap
- TORO 62.4M
- BEAT 66.1M
- IPO Year
- TORO N/A
- BEAT 2021
- Fundamental
- Price
- TORO $2.67
- BEAT $2.83
- Analyst Decision
- TORO
- BEAT Buy
- Analyst Count
- TORO 0
- BEAT 1
- Target Price
- TORO N/A
- BEAT $8.00
- AVG Volume (30 Days)
- TORO 42.7K
- BEAT 101.3K
- Earning Date
- TORO 11-12-2024
- BEAT 11-07-2024
- Dividend Yield
- TORO N/A
- BEAT N/A
- EPS Growth
- TORO N/A
- BEAT N/A
- EPS
- TORO 0.99
- BEAT N/A
- Revenue
- TORO $80,626,531.00
- BEAT N/A
- Revenue This Year
- TORO N/A
- BEAT N/A
- Revenue Next Year
- TORO N/A
- BEAT N/A
- P/E Ratio
- TORO $0.97
- BEAT N/A
- Revenue Growth
- TORO N/A
- BEAT N/A
- 52 Week Low
- TORO $2.50
- BEAT $1.06
- 52 Week High
- TORO $6.45
- BEAT $3.39
- Technical
- Relative Strength Index (RSI)
- TORO 33.33
- BEAT 66.42
- Support Level
- TORO $2.50
- BEAT $2.33
- Resistance Level
- TORO $2.79
- BEAT $3.11
- Average True Range (ATR)
- TORO 0.16
- BEAT 0.22
- MACD
- TORO -0.02
- BEAT 0.04
- Stochastic Oscillator
- TORO 18.20
- BEAT 70.79
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.